Cristina Morán-Serradilla

Ms. Cristina Morán-Serradilla

Pharmaceutical Sciences Department, University of Navarra, Pamplona, Navarre, Spain
orcid
Ph.D. student at University of Navarra

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
5 December 2022 in European Journal of Medicinal Chemistry
Verified
Journal Article
Open access
AHAndreina Henriquez-Figuereo
Andreina Henriquez-Figuereo
Cristina Morán-SerradillaCristina Morán-Serradilla
Cristina Morán-Serradilla
EAEduardo Angulo
Eduardo Angulo
Carmen SanmartinCarmen Sanmartin
Carmen Sanmartin
Plano DanielPlano Daniel
Plano Daniel
Neglected tropical diseases (NTDs) encompass a group of infectious diseases with a protozoan etiology, high incidence, and prevalence in developing countries. As a result, economic factors constitute one of the main obstacles to their management. Endemic countries have high levels of poverty, deprivation and marginalization which affect patients and limit their access to proper medical care. As a matter of fact, statistics remain uncollected in some affected areas due to non-reporting cases. World Health Organization and other organizations proposed a plan for the eradication and control of the vector, although many of these plans were halted by the COVID-19 pandemic. Despite of the available drugs to treat these pathologies, it exists a lack of effectiveness against several parasite strains. Treatment protocols for diseases such as American trypanosomiasis (Chagas disease), leishmaniasis, and human African trypanosomiasis (HAT) have not achieved the desired results. Unfortunately, these drugs present limitations such as side effects, toxicity, teratogenicity, renal, and hepatic impairment, as well as high costs that have hindered the control and eradication of these diseases. This review focuses on the analysis of a collection of scientific shreds of evidence with the aim of identifying novel chalcogen-derived molecules with biological activity against Chagas disease, leishmaniasis and HAT. Compounds illustrated in each figure share the distinction of containing at least one chalcogen element. Sulfur (S), selenium (Se), and tellurium (Te) have been grouped and analyzed in accordance with their design strategy, chemical synthesis process and biological activity. After an exhaustive revision of the related literature on S, Se, and Te compounds, 183 compounds presenting excellent biological performance were gathered against the different causative agents of CD, leishmaniasis and HAT.

16 September 2022 in Metabolites
Verified
Journal Article
Open access
PDF file
Cristina Morán-SerradillaCristina Morán-Serradilla
Cristina Morán-Serradilla
EAEduardo Angulo
Eduardo Angulo
AHAndreina Henriquez-Figuereo
Andreina Henriquez-Figuereo
Carmen SanmartinCarmen Sanmartin
Carmen Sanmartin
Arun SharmaArun Sharma
Arun Sharma
Plano DanielPlano Daniel
Plano Daniel
Selenium (Se) is an essential element for human health as it is involved in different physiological functions. Moreover, a great number of Se compounds can be considered potential agents in the prevention and treatment of some diseases. It is widely recognized that Se activity is related to multiple factors, such as its chemical form, dose, and its metabolism. The understanding of its complex biochemistry is necessary as it has been demonstrated that the metabolites of the Se molecules used to be the ones that exert the biological activity. Therefore, the aim of this review is to summarize the recent information about its most remarkable metabolites of acknowledged biological effects: hydrogen selenide (HSe−/H2Se) and methylselenol (CH3SeH). In addition, special attention is paid to the main seleno-containing precursors of these derivatives and their role in different pathologies.

11 April 2021 in Antioxidants
Verified
Journal Article
Open access
PDF file
MEMikel Etxebeste-Mitxeltorena
Mikel Etxebeste-Mitxeltorena
Plano DanielPlano Daniel
Plano Daniel
NRNora Astrain Redin
Nora Astrain Redin
Cristina Morán-SerradillaCristina Morán-Serradilla
Cristina Morán-Serradilla
CACarlos Aydillo
Carlos Aydillo
Carmen SanmartinCarmen Sanmartin
Carmen Sanmartin
Breast cancer is a multifactor disease, and many drug combination therapies are applied for its treatment. Selenium derivatives represent a promising potential anti-breast cancer treatment. This study reports the cytotoxic activity of forty-one amides and phosphoramidates containing selenium against five cancer cell lines (MCF-7, CCRF-CEM, HT-29, HTB-54 and PC-3) and two nonmalignant cell lines (184B5 and BEAS-2B). MCF-7 cells were the most sensitive and the selenoamides I.1f and I.2f and the selenium phosphoramidate II.2d, with GI50 values ranging from 0.08 to 0.93 µM, were chosen for further studies. Additionally, radical scavenging activity for all the compounds was determined using DPPH and ABTS colorimetric assays. Phosphoramidates turned out to be inactive as radical scavengers. No correlation was observed for the antioxidant activity and the cytotoxic effect, except for compounds I.1e and I.2f, which showed dual antioxidant and antitumor activity. The type of programmed cell death and cell cycle arrest were determined, and the results provided evidence that I.1f and I.2f induced cell death via autophagy, while the derivative II.2d provoked apoptosis. In addition, Western blot analysis corroborated these mechanisms with an increase in Beclin1 and LC3-IIB and reduced SQSTM1/p62 levels for I.1f and I.2f, as well as an increase in BAX, p21 and p53 accompanied by a decrease in BCL-2 levels for derivative II.2d.

Verified
Journal Article
Open access
PDF file
Cristina Morán-SerradillaCristina Morán-Serradilla
Cristina Morán-Serradilla
Plano DanielPlano Daniel
Plano Daniel
Arun SharmaArun Sharma
Arun Sharma
Carmen SanmartinCarmen Sanmartin
Carmen Sanmartin
There is an urgent need to develop safer and more effective modalities for the treatment of numerous pathologies due to the increasing rates of drug resistance, undesired side effects, poor clinical outcomes, etc. Over the past decades, cyclodextrins (CDs) have gathered great attention as potential drug carriers due to their ability to enhance their bioactivities and properties. Likewise, selenium (Se) and tellurium (Te) have been extensively studied during the last decades due to their possible therapeutical applications. Although there is limited research on the relationship between Se and Te and CDs, herein, we highlight different representative examples of the advances related to this topic as well as give our view on the future directions of this emerging area of research. This review encompasses three different aspects of this relationship: (1) modification of the structure of the different CDs; (2) formation of host–guest interaction complexes of naïve CDs with Se and Te derivatives in order to overcome specific limitations of the latter; and (3) the use of CDs as catalysts to achieve novel Se and Te compounds.

Verified
Journal Article
Open access
PDF file
SRSandra Ramos-Inza
Sandra Ramos-Inza
Cristina Morán-SerradillaCristina Morán-Serradilla
Cristina Morán-Serradilla
LGLeire Gaviria
Leire Gaviria
Arun SharmaArun Sharma
Arun Sharma
Plano DanielPlano Daniel
Plano Daniel
MFMaría Font
María Font
Commercial cyclodextrins (CDs) are commonly used to form inclusion complexes (ICs) with different molecules in order to enhance their water solubility, stability, and bioavailability. Nowadays, there is strong, convincing evidence of the anticancer effect of selenium (Se)-containing compounds. However, pharmaceutical limitations, such as an unpleasant taste or poor aqueous solubility, impede their further evaluation and clinical use. In this work, we study the enhancement of solubility with CD complexes for a set of different nonsteroidal anti-inflammatory drug (NSAID) derivatives with Se as selenoester or diacyl diselenide chemical forms, with demonstrated antitumoral activity. The CD complexes were analyzed via nuclear magnetic resonance (NMR) spectroscopic techniques. In order to obtain additional data that could help explain the experimental results obtained, 3D models of the theoretical CD-compound complexes were constructed using molecular modeling techniques. Among all the compounds, I.3e and II.5 showed a remarkable increase in their water solubility, which could be ascribed to the formation of the most stable interactions with the CDs used, in agreement with the in silico studies performed. Thus, the preliminary results obtained in this work led us to confirm the selection of β and γ-CD as the most suitable for overcoming the pharmaceutical drawbacks of these Se derivatives.

24 September 2025 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
Cristina Morán-SerradillaCristina Morán-Serradilla
Cristina Morán-Serradilla
Carmen SanmartinCarmen Sanmartin
Carmen Sanmartin
ARAsif Raza
Asif Raza
ASAmandeep Singh
Amandeep Singh
CACésar Aliaga
César Aliaga
Arun SharmaArun Sharma
Arun Sharma